Reproducibility of nifedipine absorption from GITS tablets: Comparison of single-dose pharmacokinetics using 10, 20, 40 and 60 mg nifedipine

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 1, 2004, Pages 58-62

  Tateishi, T ^a   Okumura, K ^b   Orii, Y ^b   Tanaka, T ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b BAYER YAKUHIN LTD   (Japan)

Author keywords

GITS; Intrasubject variation; Nifedipine; Pharmacokinetics

Indexed keywords

NIFEDIPINE; NITRENDIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OPEN STUDY; REPRODUCIBILITY; SINGLE DRUG DOSE; TABLET; VOLUNTEER;

EID: 0345874605     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42058     Document Type: Article

References (13)

1. Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM, Corvol P 1983 Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine. Eur J Clin Pharmacol 24: 145-150
2. Berelowitz M, Fischette C, Cefalu W, Schade DS, Sutfin T, Kourides IA 1994 Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care 17: 1460-1464
3. Brogden RN, McTavish D 1995 Nifedipine gastrointestinal therapeutic system (GITS): a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris. Drugs 50: 495-512
4. Chung M, Reitberg DP, Gaffney M, Singleton W 1987 Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. Am J Med 83: 10-14
5. Chung M, Vashi V, Puente J, Sweeney M, Meredith P 1999 Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br J Clin Pharmacol 48: 678-687
6. Davis SS, Washington N, Parr GD, Short AH, John VA, Lloyd P, Walker SM 1988 Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy. Br J Clin Pharmacol 26: 435-443
7. Grundy JS, Foster RT 1996 The nifedipine gastrointestinal therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin Pharmacokinet 30: 28-51
8. Hunt JN 1980 A possible relation between the regulation of gastric emptying and food intake. Am J Physiol 239: G1-4
9. Sastry SV, Khan MA 1998 Aqueous based polymeric dispersion: Plakett-Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system. Pharm Acta Helv 73: 105-112
10. Schneider R, Stolero D, Griffel L, Kobelt R, Brendel E, Iaina A 1994 Pharmacokinetic profile of nifedipine GITS in hypertensive patients with chronic renal impairment. Drugs 48: 16-22
11. Singleton W, Dix RK, Monsen L, Moisey D, Levenstein M, Bottiglieri DF, Silver L 1989 Efficacy and safety of Minipress XL, a new once-a-day formulation of prazosin. Am J Med 87: 45S-52S
12. Swanson DR, Barclay BL, Wong PS, Theeuwes F 1987 Nifedipine gastrointestinal therapeutic system. Am J Med 83: 3-9
13. Tateishi T, Hashimoto K, Sekino H, Matsuoka O, Kamata T, Nomura M, Okumura K, Orii Y, Kato M, Wakayama N, Tanaka T 2002 Pharmacokinetic profile of BAY a 1040 GITS, a nifedipine once-a-day dosage form based on osmotic pump configuration (in Japanese). Jap J Clin Pharmacol Ther 33: 195-204